ReviewExpert opinion on therapeutic targets2020

Preclinical insights into therapeutic targeting of KCC2 for disorders of neuronal hyperexcitability.

Phan Q Duy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.